Longboard Pharmaceuticals Stock Price Prediction
LBPH Stock | USD 59.80 0.03 0.05% |
Oversold Vs Overbought
79
Oversold | Overbought |
EPS Estimate Next Quarter (0.62) | EPS Estimate Current Year (2.27) | EPS Estimate Next Year (2.74) | Wall Street Target Price 64.6667 | EPS Estimate Current Quarter (0.58) |
Using Longboard Pharmaceuticals hype-based prediction, you can estimate the value of Longboard Pharmaceuticals from the perspective of Longboard Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Longboard Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Longboard because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Longboard Pharmaceuticals after-hype prediction price | USD 59.77 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Longboard |
Longboard Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Longboard Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Longboard Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Longboard Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
Expected price to next headline |
Longboard Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Longboard Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Longboard Pharmaceuticals' historical news coverage. Longboard Pharmaceuticals' after-hype downside and upside margins for the prediction period are 52.11 and 67.43, respectively. We have considered Longboard Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Longboard Pharmaceuticals is not too volatile at this time. Analysis and calculation of next after-hype price of Longboard Pharmaceuticals is based on 3 months time horizon.
Longboard Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Longboard Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Longboard Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Longboard Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.97 | 7.60 | 0.07 | 0.15 | 9 Events / Month | 14 Events / Month | In about 9 days |
Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
59.80 | 59.77 | 0.00 |
|
Longboard Pharmaceuticals Hype Timeline
Longboard Pharmaceuticals is now traded for 59.80. The entity has historical hype elasticity of -0.07, and average elasticity to hype of competition of -0.15. Longboard is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is now at 0.97%. %. The volatility of related hype on Longboard Pharmaceuticals is about 5082.8%, with the expected price after the next announcement by competition of 59.65. About 99.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 2.25. Longboard Pharmaceuticals had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be in about 9 days. Check out Longboard Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Longboard Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Longboard Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Longboard Pharmaceuticals' future price movements. Getting to know how Longboard Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Longboard Pharmaceuticals may potentially react to the hype associated with one of its peers.
Longboard Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Longboard price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Longboard using various technical indicators. When you analyze Longboard charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
About Longboard Pharmaceuticals Predictive Indicators
The successful prediction of Longboard Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Longboard Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Longboard Pharmaceuticals based on analysis of Longboard Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Longboard Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Longboard Pharmaceuticals's related companies. 2021 | 2022 | 2023 | 2024 (projected) | Current Ratio | 19.91 | 7.97 | 5.14 | 4.88 | Net Debt To EBITDA | 2.36 | 0.22 | 0.24 | 0.23 |
Story Coverage note for Longboard Pharmaceuticals
The number of cover stories for Longboard Pharmaceuticals depends on current market conditions and Longboard Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Longboard Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Longboard Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Longboard Pharmaceuticals Short Properties
Longboard Pharmaceuticals' future price predictability will typically decrease when Longboard Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Longboard Pharmaceuticals often depends not only on the future outlook of the potential Longboard Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Longboard Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 22.7 M | |
Cash And Short Term Investments | 48.5 M |
Complementary Tools for Longboard Stock analysis
When running Longboard Pharmaceuticals' price analysis, check to measure Longboard Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Longboard Pharmaceuticals is operating at the current time. Most of Longboard Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Longboard Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Longboard Pharmaceuticals' price. Additionally, you may evaluate how the addition of Longboard Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Stocks Directory Find actively traded stocks across global markets |